Search - tctmd.com

Displaying 1 - 20 of 51

Sort: Relevancy | Date

News Features

Funding the Future: How Industry Support for CV Trials Could Evolve

Michael O'Riordan

December 17, 2020

No Angina? No Benefit to PCI Pre-TAVR: ACTIVATION

Shelley Wood

November 26, 2020

News Daily News

Lotus Edge TAVR Device Recalled and Discontinued Worldwide

Michael O'Riordan

November 18, 2020

News Conference News AHA 2020

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

Michael O'Riordan

November 17, 2020

News Daily News

US TAVR Cases Pass a Quarter Million, Surpassing Surgery: Key Trends

Caitlin E. Cox

November 17, 2020

News Daily News

PCI at Ambulatory Centers: More Bleeding but No Penalty in Overall Outcomes

Caitlin E. Cox

November 11, 2020

News Conference News AHA 2020

AHA Calls Out Structural Racism as Driver of CVD Inequalities

Shelley Wood

November 10, 2020

News Daily News

Use of Culprit vs Multivessel PCI for STEMI Tracks With Trial Results

Todd Neale

November 04, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2020

Shelley Wood

October 30, 2020

News Daily News

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Michael O'Riordan

October 28, 2020

News Conference News TCT 2020

Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up

Michael O'Riordan

October 23, 2020

News Conference News TCT 2020

Stent Polymer Face-off Calls Bioresorbable Coatings Into Question

Shelley Wood

October 17, 2020

News Conference News TCT 2020

Sapien 3 Stroke Rate Perplexes in 1-Year SOLVE-TAVI Results

Michael O'Riordan

October 16, 2020

Presentation TCT 2020

TAVR in Low Surgical Risk Patients - Evidence Updates From Evolut Low-Risk

Presenter: Michael Reardon

October 16, 2020

News Conference News TCT 2020

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Michael O'Riordan

October 15, 2020

Presentation TCT 2020

Grading FMR Severity: Evolution of the Concept and Evolving Data

Presenter: Paul Grayburn

October 14, 2020

Presentation TCT 2020

TCT 507: We Present a Case Involving TAVI Using a Medtronik Evolut R. On Deployment of the Device, Both Coronaries Were Widely Patent and Position Appeared Good. Within 30 Minutes of Deployment, the Self-Expanding Nature of the Device Caused Obstruction…

Presenter: Matthew Mercieca Balbi

October 14, 2020

Presentation TCT 2020

TCT 473: Reproducibility of Cusp Overlap Technique to Reduce Permanent Pacemaker Implantation With Evolut – The Latin American Experience

Presenter: Hemal Gada

October 14, 2020

Presentation TCT 2020

TCT 087: Redo Transcatheter Aortic Valve Replacement With the Supra-Annular, Self-Expandable Evolut Platform: Insights From the TVT Registry

Presenter: Guilherme Attizzani

October 14, 2020

News Daily News

Young Women With AMICS: High Risk, Inadequate Care

L.A. McKeown

September 29, 2020

Advertisement

Funding the Future: How Industry Support for CV Trials Could Evolve

No Angina? No Benefit to PCI Pre-TAVR: ACTIVATION

Lotus Edge TAVR Device Recalled and Discontinued Worldwide

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

US TAVR Cases Pass a Quarter Million, Surpassing Surgery: Key Trends

PCI at Ambulatory Centers: More Bleeding but No Penalty in Overall Outcomes

AHA Calls Out Structural Racism as Driver of CVD Inequalities

Use of Culprit vs Multivessel PCI for STEMI Tracks With Trial Results

TCTMD’s Top 10 Most Popular Stories for October 2020

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up

Stent Polymer Face-off Calls Bioresorbable Coatings Into Question

Sapien 3 Stroke Rate Perplexes in 1-Year SOLVE-TAVI Results

TAVR in Low Surgical Risk Patients - Evidence Updates From Evolut Low-Risk

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Grading FMR Severity: Evolution of the Concept and Evolving Data

TCT 507: We Present a Case Involving TAVI Using a Medtronik Evolut R. On Deployment of the Device, Both Coronaries Were Widely Patent and Position Appeared Good. Within 30 Minutes of Deployment, the Self-Expanding Nature of the Device Caused Obstruction…

TCT 473: Reproducibility of Cusp Overlap Technique to Reduce Permanent Pacemaker Implantation With Evolut – The Latin American Experience

TCT 087: Redo Transcatheter Aortic Valve Replacement With the Supra-Annular, Self-Expandable Evolut Platform: Insights From the TVT Registry

Young Women With AMICS: High Risk, Inadequate Care

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content